An actualiMSCupdateI/ONTAK'spotentialmarket is>$300mI/ONTAKwas thebest deal Iever madeInsidersinvested$26.5mOur Halo-Lido trial willhave finalpatient byend of 2022There are noFDAapproveddrugs to treathemorrhoidsOnly biotechwith 2 Myron'son theleadershipteamMino-Lokpotentialmarket>$1BWe haveenough cashto go wellinto 2023I'm ashareholdermyselfWe expect tofinish theMino-Loktrial this yearHemorrhoidsis a $2BmarketThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"We willhaveexclusivityMino-Lokis our leadassetAnymentionof Mino-WrapMyron Holubiakand I founded aprivatecompany in2013I won't diluteshareholdersWe will openupinternationalsites forMino-Lok trialWe intendto submita BLA in2H 2022I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Not manycompaniesthis size with2 late stageassetsI/ONTAKis our leadassetWe had aphase 2btrial with100%efficacyAn actualiMSCupdateI/ONTAK'spotentialmarket is>$300mI/ONTAKwas thebest deal Iever madeInsidersinvested$26.5mOur Halo-Lido trial willhave finalpatient byend of 2022There are noFDAapproveddrugs to treathemorrhoidsOnly biotechwith 2 Myron'son theleadershipteamMino-Lokpotentialmarket>$1BWe haveenough cashto go wellinto 2023I'm ashareholdermyselfWe expect tofinish theMino-Loktrial this yearHemorrhoidsis a $2BmarketThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"We willhaveexclusivityMino-Lokis our leadassetAnymentionof Mino-WrapMyron Holubiakand I founded aprivatecompany in2013I won't diluteshareholdersWe will openupinternationalsites forMino-Lok trialWe intendto submita BLA in2H 2022I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Not manycompaniesthis size with2 late stageassetsI/ONTAKis our leadassetWe had aphase 2btrial with100%efficacy

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. An actual iMSC update
  2. I/ONTAK's potential market is >$300m
  3. I/ONTAK was the best deal I ever made
  4. Insiders invested $26.5m
  5. Our Halo-Lido trial will have final patient by end of 2022
  6. There are no FDA approved drugs to treat hemorrhoids
  7. Only biotech with 2 Myron's on the leadership team
  8. Mino-Lok potential market >$1B
  9. We have enough cash to go well into 2023
  10. I'm a shareholder myself
  11. We expect to finish the Mino-Lok trial this year
  12. Hemorrhoids is a $2B market
  13. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  14. We will have exclusivity
  15. Mino-Lok is our lead asset
  16. Any mention of Mino-Wrap
  17. Myron Holubiak and I founded a private company in 2013
  18. I won't dilute shareholders
  19. We will open up international sites for Mino-Lok trial
  20. We intend to submit a BLA in 2H 2022
  21. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  22. Not many companies this size with 2 late stage assets
  23. I/ONTAK is our lead asset
  24. We had a phase 2b trial with 100% efficacy